|
Medical Link Services S.A. is a spin-off of ISFI, a consulting company established in Geneva in 1994, specialized in implementing organizational systems in sectors of the service industry where data confidentiality is paramount (banking, HR & payroll, public health). All programs developed by ISFI aim at improving the quality of service delivery while reducing operating costs. In 2005, ISFI spin-offs have generated € 21 millions of income. ISFI was awarded from the Lausanne University the Stratégis Price in 1998.
Medical Link Services S.A. currently employs 10 full-time-equivalent specialists in complementary domains of medicine, organization, programming and communication.
Dr Michel Grupper, CEO and co-founder of MLS
 Dr Michel Grupper has experienced over 20 years in Public-Private Health related positions. The public sector positions include the following organizations: World Bank, WHO, DFID, MSH, GFATM, MDM, PSF. The private sector positions encompass (i) Health Economist Advisor for Europe, Middle-east & Africa for a pharmaceutical company and (ii) Health Financial analyst for a private banking company. Dr Michel Grupper also advises private foundations to implement activities world-wide by carefully monitoring its technical execution and its financial disbursement.
Publications:
DFID Health Systems Resource Centre, 2005. Proceedings of the meeting on the Production of Artemisinin and ACTs. 6-7 June 2005, Arusha, Tanzania. Convened by the Roll Back Malaria Department, World Health Organization. Dr Michel Grupper.
DFID Aligning ACT Supply and Demand: Short and Long Term Options, July 2005
World Bank: Assessment of Use of TRIPS Flexibilities to Improve Access to ARV Drugs in Africa, Report, HNP382-09-309.
DFID: Guimier JM, Lee E, Grupper M. Processes and Issues for Improving Access to Medicines. The evidence base for domestic production and greater access to medicines. Sept 2004
World Bank: CAMBODIA: Health Sector Support Project, PAD, 2002
WHO: Grupper M. Drug Cost Containment policies: a new challenge for the future. 1996, unpublished
World Bank Training Program on, HIV/AIDS Drugs, Training Module 6, Financing and Pricing |
